Article Details
Retrieved on: 2021-06-05 19:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A registration study to track outcomes of men with biochemical recurrent castrate-sensitive prostate cancer treated with peripheral androgen blockade ...
Article found on: www.docwirenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here